AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
23,564,935
Share change
+2,185,573
Total reported value
$660,436,938
Price per share
$28.01
Number of holders
79
Value change
+$64,800,303
Number of buys
42
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q3 2017

As of 30 Sep 2017, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,564,935 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Versant Venture Management, LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, BlackRock Inc., JENNISON ASSOCIATES LLC, PERCEPTIVE ADVISORS LLC, and VANGUARD GROUP INC. This page lists 79 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.